125 related articles for article (PubMed ID: 38661146)
1. VASOPRESSOR REDUCTION EFFECT OF POLYMYXIN B HEMOPERFUSION IN PATIENTS WITH PERITONITIS-INDUCED SEPTIC SHOCK: A PROPENSITY SCORE-MATCHED ANALYSIS.
Cho A; Oh SY; Lee H; Ryu HG
Shock; 2024 Jul; 62(1):69-73. PubMed ID: 38661146
[TBL] [Abstract][Full Text] [Related]
2. Potential survival benefit of polymyxin B hemoperfusion in patients with septic shock: a propensity-matched cohort study.
Nakamura Y; Kitamura T; Kiyomi F; Hayakawa M; Hoshino K; Kawano Y; Yamasaki R; Nishida T; Mizunuma M; Ishikura H;
Crit Care; 2017 Jun; 21(1):134. PubMed ID: 28592318
[TBL] [Abstract][Full Text] [Related]
3. Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial.
Payen DM; Guilhot J; Launey Y; Lukaszewicz AC; Kaaki M; Veber B; Pottecher J; Joannes-Boyau O; Martin-Lefevre L; Jabaudon M; Mimoz O; Coudroy R; Ferrandière M; Kipnis E; Vela C; Chevallier S; Mallat J; Robert R;
Intensive Care Med; 2015 Jun; 41(6):975-84. PubMed ID: 25862039
[TBL] [Abstract][Full Text] [Related]
4. Rescue therapy with polymyxin B hemoperfusion in high-dose vasopressor therapy refractory septic shock.
Monti G; Terzi V; Calini A; Di Marco F; Cruz D; Pulici M; Brioschi P; Vesconi S; Fumagalli R; Casella G
Minerva Anestesiol; 2015 May; 81(5):516-25. PubMed ID: 25319136
[TBL] [Abstract][Full Text] [Related]
5. Effects of Polymyxin B Hemoperfusion on Septic Shock Patients Requiring Noradrenaline: Analysis of a Nationwide Administrative Database in Japan.
Fujimori K; Tarasawa K; Fushimi K
Blood Purif; 2021; 50(4-5):560-565. PubMed ID: 33582663
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of postoperative polymyxin B hemoperfusion in secondary peritonitis patients with septic shock: a propensity-matched analysis.
Yuan KC; Wang SY; Yu MC; Hsu YP; Pan HC; Chen YC
Int J Artif Organs; 2017 Feb; 39(12):603-610. PubMed ID: 28165586
[TBL] [Abstract][Full Text] [Related]
7. The effect of polymyxin B hemoperfusion on modulation of human leukocyte antigen DR in severe sepsis patients.
Srisawat N; Tungsanga S; Lumlertgul N; Komaenthammasophon C; Peerapornratana S; Thamrongsat N; Tiranathanagul K; Praditpornsilpa K; Eiam-Ong S; Tungsanga K; Kellum JA
Crit Care; 2018 Oct; 22(1):279. PubMed ID: 30367647
[TBL] [Abstract][Full Text] [Related]
8. Effects of polymyxin B hemoperfusion on hemodynamics and prognosis in septic shock patients.
Lee CT; Tu YK; Yeh YC; Chang T; Shih PY; Chao A; Huang HH; Cheng YJ; Yeh YC;
J Crit Care; 2018 Feb; 43():202-206. PubMed ID: 28915395
[TBL] [Abstract][Full Text] [Related]
9. Urinary liver-type fatty acid-binding protein in septic shock: effect of polymyxin B-immobilized fiber hemoperfusion.
Nakamura T; Sugaya T; Koide H
Shock; 2009 May; 31(5):454-9. PubMed ID: 18838948
[TBL] [Abstract][Full Text] [Related]
10. Identifying Septic Shock Populations Benefitting From Polymyxin B Hemoperfusion: A Prospective Cohort Study Incorporating a Restricted Cubic Spline Regression Model.
Nakata H; Yamakawa K; Kabata D; Umemura Y; Ogura H; Gando S; Shintani A; Shiraishi A; Saitoh D; Fujishima S; Mayumi T; Kushimoto S; Abe T; Shiino Y; Nakada TA; Tarui T; Hifumi T; Otomo Y; Okamoto K; Kotani J; Sakamoto Y; Sasaki J; Shiraishi SI; Takuma K; Tsuruta R; Hagiwara A; Masuno T; Takeyama N; Yamashita N; Ikeda H; Ueyama M; Fujimi S;
Shock; 2020 Nov; 54(5):667-674. PubMed ID: 32195922
[TBL] [Abstract][Full Text] [Related]
11. Impact of polymyxin B hemoperfusion therapy on high endotoxin activity level patients after successful infection source control: a prospective cohort study.
Lee WY; Kim HJ; Kim EY
Sci Rep; 2021 Dec; 11(1):24132. PubMed ID: 34916567
[TBL] [Abstract][Full Text] [Related]
12. Direct hemoperfusion with a polymyxin B column versus vasopressin for gram negative septic shock: a matched cohort study of the effect on survival.
Sawa N; Ubara Y; Sumida K; Hiramatsu R; Hasegawa E; Yamanouchi M; Hoshino J; Suwabe T; Uchida N; Wake A; Taniguchi S; Takaichi K
Clin Nephrol; 2013 Jun; 79(6):463-70. PubMed ID: 23253903
[TBL] [Abstract][Full Text] [Related]
13. Polymyxin B-immobilized hemoperfusion and mortality in critically ill adult patients with sepsis/septic shock: a systematic review with meta-analysis and trial sequential analysis.
Fujii T; Ganeko R; Kataoka Y; Furukawa TA; Featherstone R; Doi K; Vincent JL; Pasero D; Robert R; Ronco C; Bagshaw SM
Intensive Care Med; 2018 Feb; 44(2):167-178. PubMed ID: 29204670
[TBL] [Abstract][Full Text] [Related]
14. Uncertain Clinical Effect of Polymyxin B Hemoperfusion in Patients with Septic Acute Kidney Injury Requiring Continuous Renal Replacement Therapy.
Lee JM; Baek SD; Kim TH; Jeon HR; Han JH; Chang JW
Shock; 2021 Oct; 56(4):551-556. PubMed ID: 33606479
[TBL] [Abstract][Full Text] [Related]
15. Polymyxin B hemoperfusion as a feasible therapy after source control in abdominal septic shock.
Kim JJ; Park YJ; Moon KY; Park JH; Jeong YK; Kim EY
World J Gastrointest Surg; 2019 Dec; 11(12):422-432. PubMed ID: 31879534
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness analysis of polymyxin-B immobilized fiber column and conventional medical therapy in the management of abdominal septic shock in Italy.
Berto P; Ronco C; Cruz D; Melotti RM; Antonelli M
Blood Purif; 2011; 32(4):331-40. PubMed ID: 22086346
[TBL] [Abstract][Full Text] [Related]
17. Exacerbation of prothrombin time-international normalized ratio before second polymyxin B cartridge hemoperfusion predicts poor outcome of patients with severe sepsis and/or septic shock.
Ishizuka M; Terasaki A; Kubota K
J Surg Res; 2016 Jan; 200(1):308-14. PubMed ID: 26319975
[TBL] [Abstract][Full Text] [Related]
18. Polymyxin B hemoperfusion in endotoxemic septic shock patients without extreme endotoxemia: a post hoc analysis of the EUPHRATES trial.
Klein DJ; Foster D; Walker PM; Bagshaw SM; Mekonnen H; Antonelli M
Intensive Care Med; 2018 Dec; 44(12):2205-2212. PubMed ID: 30470853
[TBL] [Abstract][Full Text] [Related]
19. Potential Survival Benefit of Polymyxin B Hemoperfusion in Septic Shock Patients on Continuous Renal Replacement Therapy: A Propensity-Matched Analysis.
Iwagami M; Yasunaga H; Noiri E; Horiguchi H; Fushimi K; Matsubara T; Yahagi N; Nangaku M; Doi K
Blood Purif; 2016; 42(1):9-17. PubMed ID: 26918904
[TBL] [Abstract][Full Text] [Related]
20. Polymyxin B hemoperfusion in coronavirus disease 2019 patients with endotoxic shock: Case series from EUPHAS2 registry.
De Rosa S; Cutuli SL; Ferrer R; Antonelli M; Ronco C;
Artif Organs; 2021 Jun; 45(6):E187-E194. PubMed ID: 33377184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
